Results 231 to 240 of about 8,567,027 (419)

REMARKS ON THE METROPOLITAN HOSPITAL SUNDAY FUND: Delivered at the Mansion House on the occasion of the Hospital Sunday Fund Presenting to the Mansion House a Bust of the late Mr. George Herring [PDF]

, 1908
Heather Morris
openalex   +1 more source

Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance

Molecular Oncology, EarlyView.
Cellular heterogeneity is a major cause of drug resistance in cancer. Segeren et al. used single‐cell transcriptomics to investigate gene expression events that correlate with sensitivity to the DNA‐damaging drugs gemcitabine and prexasertib. They show that dampened expression of transcription factor FOXM1 and its target genes protected cells against ...
Hendrika A. Segeren, Kathryn A. Wierenga, Frank M. Riemers, Elsbeth A. van Liere, Bart Westendorp   +4 more
wiley   +1 more source

Resident funding and care home quality: a retrospective observational analysis of the impact of the two-tier care system in England. [PDF]

Age Ageing
Bach-Mortensen A, Goodair B, Degli Esposti M, Corlet Walker C.   +3 more
europepmc   +1 more source

R.A.M.C. FUND AND R.A.M.C. OFFICERS' BENEVOLENT SOCIETY. [PDF]

, 1919
E.M. Wilson
openalex   +1 more source

Targeting PRAME directly or via EZH2 inhibition overcomes retinoid resistance and represents a novel therapy for keratinocyte carcinoma

Molecular Oncology, EarlyView.
The study evaluated the function and therapeutic implications of PRAME in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The findings demonstrate that PRAME impairs keratinocyte differentiation pathways. Furthermore, PRAME impairs anticancer response to retinoid compounds in BCC and SCC cells.
Brandon Ramchatesingh, Amelia Martinez Villarreal, Philippe Lefrançois, Jennifer Gantchev, Sriraam Sivachandran, Samy Abou Setah, Ivan V. Litvinov   +6 more
wiley   +1 more source

Expression of concern for global biomedical research by the human genome organization (HUGO). [PDF]

Hum Genomics
Hamosh A, Arzuaga F, B Avraham K, Bin Alwi Z, Bowcock A, Burn SJ, Carninci P, Dandara C, Lopes-Cendes I, Mutesa L, P Majumder P, K V Reichardt J, A Veltman J.   +12 more
europepmc   +1 more source

THE MILWARD FUND: A LETTER OF THANKS. [PDF]

, 1914
E.S. Dorothy Milward
openalex   +1 more source

Further Education Funding Council : circular 00/29 : funding : final funding unit return [PDF]

, 2000

core  

Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value

Molecular Oncology, EarlyView.
The Unsupervised AML Multi‐Omics Classification System (UAMOCS) integrates genomic, methylation, and transcriptomic data to categorize AML patients into three subtypes (UAMOCS1‐3). This classification reveals clinical relevance, highlighting immune and chromosomal characteristics, prognosis, and therapeutic vulnerabilities.
Yang Song, Zhe Wang, Guangji Zhang, Jiangxue Hou, Kaiqi Liu, Shuning Wei, Yan Li, Chunlin Zhou, Dong Lin, Min Wang, Hui Wei, Jianxiang Wang, Tao Cheng, Yingchang Mi   +13 more
wiley   +1 more source

Inequity of NIH cancer funding in the United States: an ecological study predicting funding based on disease burden from 2008 through 2023. [PDF]

Lancet Reg Health Am
Berglas E, Musheyev D, Lavi AB, Berglas RS, Berglas R, Kabarriti AE.   +5 more
europepmc   +1 more source